Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)

© 2019, The Author(s). The Open Access license, which previously read: Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creat iveco mmons .org/licen ses/by-nc/4.0/), which permits any noncommercial use, distri...

Saved in:

書目詳細資料
Main Authors:	Sermsiri Sangroongruangsri, Usa Chaikledkaew, Suthasinee Kumluang, Olivia Wu, Claudia Geue, Tanapat Ratanapakorn, Pattara Leelahavarong, Lily Ingsrisawang, Paisan Ruamviboonsuk, Wongsiri Taweebanjongsin, Janejit Choovuthayakorn, Apichart Singalavanija, Prut Hanutsaha, Kittisak Kulvichit, Thitiporn Ratanapojnard, Warapat Wongsawad, Yot Teerawattananon
格式:	雜誌
出版:	2019
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060336580&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/63714
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study (Clinical Drug Investigation, (2018), 38, 9, (853-865), 10.1007/s40261-018-0678-5)
由: Sermsiri Sangroongruangsri, et al.
出版: (2020)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
由: Sermsiri Sangroongruangsri, et al.
出版: (2018)

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
由: Sermsiri Sangroongruangsri, et al.
出版: (2019)

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
由: Suthasinee Kumluang, et al.
出版: (2019)

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
由: Suthasinee Kumluang, et al.
出版: (2020)

Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: Results of a 1-year preliminary study
由: Paisan Ruamviboonsuk, et al.
出版: (2018)

Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
由: Sermsiri Sangroongruangsri, et al.
出版: (2019)

Cost-utility analysis of drug treatments in patients with polypoidal choroidal vasculopathy in Thailand
由: Sermsiri Sangroongruangsri, et al.
出版: (2022)

The structural prerequisites for the implementation of PHC: A comparative case study of Barangays 865 and 834
由: Fecundo, Ramon, et al.
出版: (1989)

The structural prerequisites for the implementation of PHC: A comparative case study of Barangays 865 and 834
由: Fecundo, Ramon, et al.
出版: (1989)

Cost-effectiveness analysis of vision screening program in schools under Bangkok metropolitan authority
由: Prut Hanutsaha
出版: (2003)

Assessment of the urban primary health care approach: A case study of Bgy. 865 in Pandacan, Manila
由: Lipana, Marcel Charles C., et al.
出版: (1996)

Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
由: Joseph, Rini Rachel, et al.
出版: (2018)

Bioactivty and controlled release studies of ranibizumab from polymeric carriers
由: Chua, Hui Yee
出版: (2018)

Formulation and in-vitro release studies of Ranibizumab (Lucentis) loaded liposomes
由: Ang, Jin Yan
出版: (2013)

Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments
由: Voraporn Chaikitmongkol, et al.
出版: (2018)

Intraretinal fibrosis in exudative diabetic macular edema after ranibizumab treatments
由: Voraporn Chaikitmongkol, et al.
出版: (2018)

DESIGN, MODEL, AND SIMULATION OF PELTON WATER TURBINE WITH HEAD OF 86.5 M AND DISCHARGE 3,5 M\TEXTSUPERSCRIPT{3}/S.
由: Suyudhi Suryakusuma, Muhammad

Epitop Regio P(824-853) Antigen I/II Streptococcus Mutans Serotipe C yang Reaktif dalam Patogenesis Karies Gigi di Surabaya
由: Anita Yuliati
出版: (2024)

One-step solid-oil-water emulsion for sustained bioactive ranibizumab release
由: Chua, Hui Yee, et al.
出版: (2020)

Intravitreal Ranibizumab Treatment for Non-Proliferative Idiopathic Macular Telangiectasia Article Sidebar
由: Wichai Prasartritha, et al.
出版: (2022)

Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)
由: Somanus Thoongsuwan, et al.
出版: (2022)

Epidemiology of age-related macular degeneration among the elderly population in Thailand
由: Rossukon Khotcharrat, et al.
出版: (2018)

Epidemiology of age-related macular degeneration among the elderly population in Thailand
由: Rossukon Khotcharrat, et al.
出版: (2018)

RADIANCE: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia
由: Wolf, S., et al.
出版: (2016)

Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularization
由: Moreno, Miguel, et al.
出版: (2017)

Dramatic resolution of choroidal neovascular abnormalities after single aflibercept injection following years of ranibizumab use
由: Chaikitmongkol V., et al.
出版: (2014)

Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration
由: Wickremasinghe, S.S., et al.
出版: (2014)

Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD
由: Wickremasinghe, S.S., et al.
出版: (2014)

Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period
由: Wickremasinghe, S.S., et al.
出版: (2014)

Economic Evaluations of Artificial Intelligence in Ophthalmology
由: Paisan Ruamviboonsuk, et al.
出版: (2022)

Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment
由: Mitchell P., et al.
出版: (2018)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
由: Thunyarat Anothaisintawee, et al.
出版: (2018)

Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion
由: Tan, M.H., et al.
出版: (2014)

Photodynamic therapy for AMD and non-AMD patients: One-year results in Thais
由: Mansing Ratanasukon, et al.
出版: (2018)

Photodynamic therapy for AMD and non-AMD patients: One-year results in Thais
由: Mansing Ratanasukon, et al.
出版: (2018)

Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: A pilot study
由: Kaevalin Lekhanont, et al.
出版: (2018)

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration /692/699/3161/1626 /692/699/3161/3175 article
由: Yamashiro, K, et al.
出版: (2020)

Clinical equivalence between a combination of 1% tropicamide/2.5% phenylephrine hydrochloride and 1% tropicamide/10% phenylephrine in pupillary dilatation efficacy in dark irides: a double blind randomized controlled trial
由: Kittisak Kulvichit
出版: (2009)

Clinical equivalence between a combination of 1% tropicamide/2.5% phenylephrine hydrochloride and 1% tropicamide/10% phenylephrine in pupillary dilatation efficacy in dark irides: a double blind randomized controlled trial
由: Kittisak Kulvichit
出版: (2001)